Medtech Mega Mergers: Cautionary Tale or Compelling Growth Strategy?Medtech Mega Mergers: Cautionary Tale or Compelling Growth Strategy?

11d ago, source: MD&M East

This week in Pedersen’s POV, our senior editor revisits the trend of mega mergers in the medical device industry through a ...

J&J CEO says M&A strategy 'will continue' after medtech megadeals

3d ago, source: FierceBiotech

After setting up more than $30 billion in medtech M&A spending within less than two years, Johnson & Johnson CEO Joaquin ...

Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says

11d ago, source:

Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a ...

J&J CFO: We've 'beefed up' cardiovascular medical devices in hopes of reviving our medtech business

3d ago, source:

J&J is doubling down on medtech, a typically sleepy sector that has been risky, as it looks to grow after spinning of ...

J&J scoops up cardio medtech Shockwave Medical for $13.1B

14d ago, source: MM&M

Following closure of the deal, Shockwave will operate as a business unit within J&J MedTech and its financials will be ...

23andMine: CEO Anne Wojcicki aims to take genetics company private

1d ago, source: FierceBiotech

23andMe’s co-founder and CEO Anne Wojcicki has put in motion a plan to take the company private after the stock value of the ...

Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?

on MSN ago, source:

What does this mean for the company, and does this move make Johnson & Johnson an attractive option for growth investors? The ...

Sanara MedTech Inc. Announces $55 Million Debt Facility

1d ago, source:

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and ...

Johnson & Johnson bolsters MedTech segment again with another sizable acquisition (JNJ)

14d ago, source: Briefing.com

For FY24, the company guided for revenue ... JNJ is financing the acquisition with cash on hand and debt. From an operational standpoint, though, the transaction is expected to be accretive to JNJ's ...

23andMe CEO plans to take company private

1d ago, source: medtechdive

Anne Wojcicki wants to buy all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?

9d ago, source: Nasdaq

The acquisition of Shockwave Medical is a good way for Johnson & Johnson to strengthen its medtech business, but it's still a fairly modest purchase for a company of J&J's size and stature.